Literature DB >> 3042203

Lipoprotein subspecies and risk of coronary disease.

T A Musliner1, R M Krauss.   

Abstract

This review summarizes physical and chemical properties of major subspecies of very-low-, low-, intermediate, and high-density lipoproteins. Hypotheses regarding the metabolic origins of these subspecies and evidence for their associations with risk of coronary artery disease are presented.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3042203

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


  15 in total

Review 1.  Beta-blockers in the management of hypertension in patients with type 2 diabetes mellitus: is there a role?

Authors:  F Dunne; M J Kendall; U Martin
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  LDL particle size: an important drug target?

Authors:  I Rajman; P I Eacho; P J Chowienczyk; J M Ritter
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

3.  Women with gestational diabetes should be targeted to reduce cardiovascular risk.

Authors:  V Toescu; S L Nuttall; M J Kendall; U Martin; F Dunne
Journal:  BMJ       Date:  2002-10-26

4.  The distribution profiles of very low density and low density lipoproteins in poorly-controlled male, type 2 (non-insulin-dependent) diabetic patients.

Authors:  R W James; D Pometta
Journal:  Diabetologia       Date:  1991-04       Impact factor: 10.122

5.  Evaluation of serum lipids and high-density lipoprotein subfractions (HDL2, HDL3) in postmenopausal patients with breast cancer.

Authors:  V Michalaki; G Koutroulis; K Syrigos; C Piperi; A Kalofoutis
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

6.  Novel lipoprotein subfraction and size measurements in prediction of mortality in maintenance hemodialysis patients.

Authors:  Nazanin Noori; Michael P Caulfield; Wael A Salameh; Richard E Reitz; Susanne B Nicholas; Miklos Z Molnar; Allen R Nissenson; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Clin J Am Soc Nephrol       Date:  2011-10-27       Impact factor: 8.237

7.  Prospective study of coronary heart disease vs. HDL2, HDL3, and other lipoproteins in Gofman's Livermore Cohort.

Authors:  Paul T Williams; Daniel E Feldman
Journal:  Atherosclerosis       Date:  2010-10-23       Impact factor: 5.162

8.  Oxidative susceptibility of low density lipoprotein subfractions is related to their ubiquinol-10 and alpha-tocopherol content.

Authors:  D L Tribble; J J van den Berg; P A Motchnik; B N Ames; D M Lewis; A Chait; R M Krauss
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

9.  APOE genotype affects black-white responses of high-density lipoprotein cholesterol subspecies to aerobic exercise training.

Authors:  Thomas O Obisesan; Robert E Ferrell; Andrew P Goldberg; Dana A Phares; Tina J Ellis; James M Hagberg
Journal:  Metabolism       Date:  2008-12       Impact factor: 8.694

10.  Lipoprotein particle distribution and size, insulin resistance, and metabolic syndrome in Alaska Eskimos: the GOCADAN study.

Authors:  Angela A Rivellese; Lidia Patti; David Kaufman; Jianhui Zhu; Giovanni Annuzzi; Olga Vaccaro; Sven O Ebbesson; Wm James Howard; Gabriele Riccardi; Barbara V Howard
Journal:  Atherosclerosis       Date:  2008-04-18       Impact factor: 5.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.